FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Hemp Based CBD

  • Home
  •  | 
  • Tag Archives: "Hemp Based CBD"

Revive Therapeutics Introduces RELICANN™ a New Brand for Hemp-based CBD Wellness and Medical Cannabis Market

Revive Therapeutics Introduces RELICANN™ a New Brand for Hemp-based CBD Wellness and Medical Cannabis Market
Sept. 11, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, today announced the introduction of RELICANN™, the Company’s hemp-based  and medical cannabis brand designed for the health and wellness and medical cannabis consumer.  The Company’s first product under the RELICANN™ brand is RELICANN™ hemp-based Cannabidiol (“CBD”) gum, which will be available in Canada in the fourth-quarter of 2018.
Read more

Naturally Splendid Increases Vertical Integration and Expands International Footprint

Naturally Splendid Increases Vertical Integration and Expands International Footprint
The cannabis industry tends to capture a lot of headlines these days, but investors shouldn’t ignore the hemp industry’s massive potential. With hemp-based CBD oil growing in popularity, the market is projected to top $10 billion over the coming years, and there are only a handful of companies building strong brands in the space. Investors may want to take note of these companies as potential opportunities.
Read more

American Pain Association President Selects Tree of Knowledge as CBD Supplier — CFN Media

American Pain Association President Selects Tree of Knowledge as CBD Supplier — CFN Media
Cannabidiol, or CBD, has been widely studied for its potential benefits in improving a wide range of medical conditions. While there are many different suppliers of CBD oils, tinctures, and other products, there are few that are trusted by medical professionals willing to prescribe it to their patients. Investors may want to take a closer look at these providers as potential opportunities in the space—particularly those that are already building distribution inroads.
Read more